Freiburg Hosts Free Public Forum on Crohn's and Ulcerative Colitis Advances

Freiburg Hosts Free Public Forum on Crohn's and Ulcerative Colitis Advances

Sylvia Jordan
Sylvia Jordan
2 Min.
A group of people seated around a table with food and drinks, with boxes and papers labeled "Cholera Consultation - The Central Board of Health" on the right side.

Freiburg Hosts Free Public Forum on Crohn's and Ulcerative Colitis Advances

A public event on chronic inflammatory bowel disease (IBD) will take place in Freiburg on November 29, 2025. Organised by the German Crohn's and Ulcerative Colitis Association (DCCV e.V.) and the Department of Internal Medicine II at Freiburg University Medical Center, the gathering aims to inform patients, families, and the public about the latest advancements in treatment and support. Entry is free, and no prior registration is needed.

The event begins at 9:30 AM in the Large Lecture Hall of the Medical Clinic, Freiburg. Experts will discuss recent progress in IBD research, covering new drug therapies and surgical options. Attendees will also learn about available counselling and support services for those living with the condition.

Over half a million people in Germany currently live with IBD, including Crohn's disease and ulcerative colitis. Official figures estimate around 300,000 cases of ulcerative colitis and 250,000 cases of Crohn's disease, with only a slight rise in diagnoses over time. The programme will close with an open discussion, giving participants the chance to ask questions and share their experiences.

A detailed schedule of talks and activities is available in the event flyer. Organisers encourage anyone affected by IBD, as well as their relatives and carers, to attend and engage with specialists in the field.

The event provides an opportunity for patients and their families to access expert knowledge and connect with others facing similar challenges. With free admission and no registration required, organisers hope to reach a wide audience and offer practical support to those affected by IBD.

Neueste Nachrichten